Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Atyr Pharma Inc
(NQ:
LIFE
)
1.900
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.900
Bid (Size)
1.900 (15)
Ask (Size)
1.950 (20)
Prev. Close
1.900
Today's Range
1.900 - 1.900
52wk Range
1.080 - 2.150
Shares Outstanding
54,291,754
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025
June 05, 2024
These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real.
Via
InvestorPlace
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
June 03, 2024
Ticker symbol change to take effect on Wednesday, June 5, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Performance
YTD
+27.09%
+27.09%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+2.70%
+2.70%
1 Year
+37.68%
+37.68%
More News
Read More
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 24, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Recap: aTyr Pharma Q4 Earnings
March 14, 2024
Via
Benzinga
aTyr Pharma's Earnings Outlook
March 13, 2024
Via
Benzinga
Analyst Expectations for aTyr Pharma's Future
September 21, 2023
Via
Benzinga
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
May 15, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
May 14, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma to Present at Upcoming Investor Conferences
May 06, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
LIFE Stock Earnings: aTyr Pharma Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
Via
InvestorPlace
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
May 02, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Via
InvestorPlace
LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023
March 14, 2024
Via
InvestorPlace
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
March 14, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
February 28, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 14, 2024
March 14, 2024
Via
Benzinga
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
February 21, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
The 3 Best Penny Stocks to Buy in February 2024
February 15, 2024
Via
InvestorPlace
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
January 18, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!
November 13, 2023
Via
IssueWire
Topics
Religion
Exposures
Religion
aTyr Pharma to Present at November Investor Conferences
November 01, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
October 31, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.